How is non-obviousness in improvement drug invention patents assessed?
Wu Xiaoping and Hu Honghui of Wanhuida examine the methodology employed by the Patent Reexamination Board to determine non-obviousness of an improvement invention
Drug invention patents are dedicated to protecting multiple types of inventions, including compounds, crystal forms, dosage forms, preparation methods and uses. Due to the high entry threshold, the research and development of drugs can be a pricey and lengthy process...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.